Bullish
Thermo Fisher Scientific (TMO) announced a quarterly dividend of $0.47 per share, maintaining its previous payout, which reflects the company's commit...
Bullish
Thermo Fisher Scientific Inc. (NYSE: TMO) announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share. This d...
Bullish
Thermo Fisher Scientific (NYSE: TMO) held its Investor Day, where Chairman and CEO Marc N. Casper emphasized the company's strong industry leadership,...
Thermo Fisher Scientific highlighted its industry leadership, growth outlook, and long-term value creation at its 2026 Investor Day. The company serve...
Neutral
Former President Trump has been found to invest in companies and then promote them in his public speeches, often on the same day as his stock purchase...
Bullish
Thermo Fisher Scientific (TMO) stock has dropped 31% from its 52-week high despite reporting a Q1 2026 earnings beat and raising full-year EPS guidanc...
Bullish
This article details Thermo Fisher Mikroskop products, emphasizing their central role in laboratory imaging for US facilities. It covers their use in ...
Bullish
Thermo Fisher Scientific has opened a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, enhancing its global capabilities to support d...
Neutral
Donald Trump's recent financial disclosure reveals instances where he purchased stock in companies on the same day or shortly before publicly praising...
Bullish
Thermo Fisher Scientific reported stronger-than-expected Q1 2026 earnings, beating analyst estimates for both EPS and revenue, and raised its dividend...
Neutral
Ameritas Advisory Services LLC increased its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 525.2% in the fourth quarter, accor...
Bullish
Thermo Fisher Scientific reported strong Q1 2026 earnings, with EPS of $5.44, surpassing consensus estimates by 4.62%. This performance, coupled with ...
Thermo Fisher Scientific (TMO) recently reported strong earnings and raised its full-year forecast, despite a recent stock price decline of over 13% i...
Bullish
The Transfection Reagents Market is projected to experience rapid growth between 2026 and 2033, driven by increasing demand and continuous innovation....
Bullish
Thermo Fisher Scientific, a prominent Massachusetts-based biotech company, has inaugurated a new, highly anticipated lab and processing facility. The ...
Bullish
Thermo Fisher Scientific has opened its first U.S. bioprocess design center in Plainville, Massachusetts, expanding its existing 290,000-square-foot c...
Bullish
Thermo Fisher Scientific has agreed to sell its microbiology business to Astorg, a pan-European private equity firm, for approximately $1.075 billion....
Thermo Fisher Scientific (TMO) shares declined after Q1 2026 earnings, despite revenue reaching US$11.01b and GAAP diluted EPS of US$4.43, as the comp...
Neutral
Thermo Fisher Scientific announced it has signed a definitive agreement to sell its microbiology business to Astorg for approximately $1.075 billion. ...
Bullish
Thermo Fisher Scientific (NYSE: TMO) announced strong financial results for fiscal Q1 2026, with revenue rising 6% to $11.01 billion and GAAP diluted ...